PMC:7212965 / 94739-95894
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T234 | 365-380 | Body_part | denotes | Digestive tract | http://purl.org/sig/ont/fma/fma317863 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T193 | 365-380 | Body_part | denotes | Digestive tract | http://purl.obolibrary.org/obo/UBERON_0001555 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T450 | 99-107 | Disease | denotes | Diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
T451 | 235-243 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T452 | 266-274 | Disease | denotes | diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
T453 | 355-363 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T454 | 471-479 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T455 | 1075-1083 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T751 | 172-177 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
T752 | 252-254 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T753 | 277-279 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T754 | 305-310 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
T755 | 365-380 | http://purl.obolibrary.org/obo/UBERON_0001555 | denotes | Digestive tract |
T756 | 395-398 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
T757 | 413-416 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T267 | 49-51 | Chemical | denotes | GI | http://purl.obolibrary.org/obo/CHEBI_73907 |
T268 | 172-177 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
T269 | 193-204 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
T270 | 209-218 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T271 | 220-229 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T272 | 244-246 | Chemical | denotes | NR | http://purl.obolibrary.org/obo/CHEBI_145751 |
T273 | 247-249 | Chemical | denotes | NR | http://purl.obolibrary.org/obo/CHEBI_145751 |
T274 | 305-310 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
T275 | 319-330 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
T276 | 334-341 | Chemical | denotes | arbidol | http://purl.obolibrary.org/obo/CHEBI_134730 |
T277 | 408-410 | Chemical | denotes | NR | http://purl.obolibrary.org/obo/CHEBI_145751 |
T278 | 425-434 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T279 | 435-444 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T280 | 618-623 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T281 | 643-648 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T282 | 667-672 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T283 | 692-697 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T284 | 716-721 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T285 | 742-747 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T286 | 757-760 | Chemical | denotes | AST | http://purl.obolibrary.org/obo/CHEBI_76649 |
T287 | 800-805 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T288 | 858-863 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T289 | 999-1010 | Chemical | denotes | Chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T443 | 68-83 | Phenotype | denotes | Nausea/vomiting | http://purl.obolibrary.org/obo/HP_0002017 |
T444 | 84-98 | Phenotype | denotes | Abdominal pain | http://purl.obolibrary.org/obo/HP_0002027 |
T445 | 99-107 | Phenotype | denotes | Diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
T446 | 108-116 | Phenotype | denotes | Jaundice | http://purl.obolibrary.org/obo/HP_0000952 |
T447 | 266-274 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
T448 | 501-507 | Phenotype | denotes | nausea | http://purl.obolibrary.org/obo/HP_0002018 |
T449 | 515-523 | Phenotype | denotes | vomiting | http://purl.obolibrary.org/obo/HP_0002013 |
T450 | 559-565 | Phenotype | denotes | nausea | http://purl.obolibrary.org/obo/HP_0002018 |
T451 | 580-588 | Phenotype | denotes | vomiting | http://purl.obolibrary.org/obo/HP_0002013 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T957 | 0-67 | Sentence | denotes | Medication class Medication Sourcea Study Design GI adverse effects |
T958 | 68-131 | Sentence | denotes | Nausea/vomiting Abdominal pain Diarrhea Jaundice Hepatotoxicity |
T959 | 132-286 | Sentence | denotes | Antiviral Favipiravir Cai, 2020109 Open-label control study (favipiravir and lopinavir/ ritonavir) for COVID-19 NR NR 2/35 (5.7%) had diarrhea 1/35 (2.9%) |
T960 | 287-424 | Sentence | denotes | Chen, 202092 Open-label RCT for favipiravir vs arbidol (n = 120) in COVID-19 “Digestive tract reactions” 16/116 (13.79%) NR 9/116 (7.76%) |
T961 | 425-761 | Sentence | denotes | Lopinavir/ritonavir Cao,89 2020 RCT in severe COVID-19 (n = 199) 10/95 with nausea + 6/96 vomiting (reported separately) vs 0/99 with nausea and 0/99 with vomiting in control 4/95 in treatment group vs 2/99 in control group 4/95 in treatment group vs 0/99 in control group 6/95 in treatment group vs. 5/99 in control group Elevated AST: |
T962 | 762-820 | Sentence | denotes | 4/95 in treatment vs. 9/99 in control group; Elevated ALT: |
T963 | 821-863 | Sentence | denotes | 2/95 in treatment vs 5/99 in control group |
T964 | 864-985 | Sentence | denotes | Remdesivir Holshue,103 2020 Case report (first COVID in United States): remdesvir given day 7; no adverse events reported |
T965 | 986-1136 | Sentence | denotes | Antimalarial Chloroquine Cortegiani,104 2020 Systematic review on efficacy and safety in COVID-19 Not reported in systematic review or primary studies |
T966 | 1137-1155 | Sentence | denotes | Hydroxychloroquine |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2515 | 816-822 | Gene | denotes | ALT: 2 | Gene:84706 |
2516 | 49-51 | Gene | denotes | GI | Gene:2770 |
2517 | 209-229 | Chemical | denotes | lopinavir/ ritonavir | MESH:C558899 |
2518 | 425-444 | Chemical | denotes | Lopinavir/ritonavir | MESH:C558899 |
2519 | 864-874 | Chemical | denotes | Remdesivir | MESH:C000606551 |
2520 | 68-74 | Disease | denotes | Nausea | MESH:D009325 |
2521 | 75-131 | Disease | denotes | vomiting Abdominal pain Diarrhea Jaundice Hepatotoxicity | MESH:D015746 |
2522 | 235-243 | Disease | denotes | COVID-19 | MESH:C000657245 |
2523 | 266-274 | Disease | denotes | diarrhea | MESH:D003967 |
2524 | 355-363 | Disease | denotes | COVID-19 | MESH:C000657245 |
2525 | 471-479 | Disease | denotes | COVID-19 | MESH:C000657245 |
2526 | 501-507 | Disease | denotes | nausea | MESH:D009325 |
2527 | 515-523 | Disease | denotes | vomiting | MESH:D014839 |
2528 | 559-565 | Disease | denotes | nausea | MESH:D009325 |
2529 | 580-588 | Disease | denotes | vomiting | MESH:D014839 |
2530 | 911-916 | Disease | denotes | COVID | MESH:C000657245 |
2531 | 1075-1083 | Disease | denotes | COVID-19 | MESH:C000657245 |